Hostname: page-component-cd4964975-pf4mj Total loading time: 0 Render date: 2023-03-29T07:43:00.951Z Has data issue: true Feature Flags: { "useRatesEcommerce": false } hasContentIssue true

A surface antigen influenza vaccine: 2. Pyrogenicity and antigenicity

Published online by Cambridge University Press:  15 May 2009

Margaret I. Brady
Evans Biologicals Ltd, Speke, Liverpool L24 9JD
I. G. S. Furminger
Evans Biologicals Ltd, Speke, Liverpool L24 9JD
Rights & Permissions[Opens in a new window]


HTML view is not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Conventional influenza vaccine containing whole virus particles purified on a zonal centrifuge is pyrogenic and can cause systemic and local adverse side effects. An improved vaccine was therefore prepared which contained only the surface antigens of the virus adsorbed to aluminium hydroxide. The antigenicity of this vaccine was compared with conventional vaccine in chickens. Both vaccines induced similar titres of serum haemagglutination-inhibition and neuraminidase inhibition antibody. The dose response curves, however, were different. The surface antigens at vaccine strength without aluminium hydroxide were of negligible pyrogenicity in rabbits.

Research Article
Copyright © Cambridge University Press 1976



Brady, M. I. & Furminger, I. G. S. (1976). A surface antigen influenza vaccine. 1. Purification of haemagglutinin and neuraminidase proteins. Journal of Hygiene 77, 161–72.CrossRefGoogle ScholarPubMed
Brady, M. I. & Furminger, I. G. S. (1975). The protection of ferrets against influenza by immunization with a split influenza vaccine. International symposium on immunity to infections of the respiratory system. Developments in Biological Standardisation 28, 167–72.Google Scholar
Brady, M. I., Furminger, I. G. S. & Stones, P. B. (1976). An adsorbed surface antigen influenza vaccine and its serological activity in human volunteers. Postgraduate Medical Journal 52, 368–72.CrossRefGoogle Scholar
Brand, C. M. & Skehel, J. J. (1972). Crystalline antigen from the influenza virus envelope. Nature, New Biology 238, 145–7.CrossRefGoogle ScholarPubMed
Davenport, F. M., Hennessy, A. V., Brandon, F. M., Webster, R. G., Barrett, C. D. Jr. & Lease, G. O. (1964). Comparisons of serological and febrile responses in humans to vaccination with influenza A viruses or their haemagglutinins. Journal of Laboratory and Clinical Medicine 64, 513.Google Scholar
Dowdle, W. R., Mostow, S. R., Coleman, M. T. & Kaye, H. S. (1973). Inactivated influenza vaccines. 2. Laboratory indices of protection. Postgraduate Medical Journal 49, 159–63.CrossRefGoogle ScholarPubMed
Duxbury, A. E., Hampson, A. W. & Sievers, J. G. M. (1968). Antibody response in humans to deoxycholate-treated influenza virus vaccine. Journal of Immunology 101, 62–7.Google ScholarPubMed
Grossebauer, K., Langmaäck, H., Schmidt, B. & Kucchler, R. (1969). Enhancement and neutralisation of pyrogenicity of influenza viruses by biologically active substances. Archiv für die gesamte Virusforschung 28, 151–64.CrossRefGoogle Scholar
Hennessy, A. V. & Davenport, F. M. (1974). Studies on vaccination of infants against influenza with influenza haemagglutinin. Proceedings of the Society for Experimental Biology and Medicine 146, 200204.CrossRefGoogle Scholar
Hobson, D., Curry, R. L., Beare, A. S. & Ward-Gardner, A. (1972). The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. Journal of Hygiene 70, 767–77.CrossRefGoogle ScholarPubMed
Jennings, R., Brand, C. M., McLaren, C., Shepherd, Lynda & Potter, C. W. (1974). The immune response of hamsters to purified haemagglutinins and whole influenza virus vaccine following live influenza virus infection. Journal of Medical Microbiology and Immunology 160, 295309.CrossRefGoogle ScholarPubMed
Jennings, R., Potter, C. W., McLaren, C. & Brady, M. I. (1975). A new surface antigen adsorbed influenza virus vaccine. I. Studies on immunogenicity in hamsters. Journal of Hygiene 75, 341–52.CrossRefGoogle ScholarPubMed
Kendal, A. P. (1967). Automation of a thiobarbituric acid method for determining free sialic acid. Automation and Analytical Chemistry – European Technicon Symposium, Brighton, England.Google Scholar
Neurath, A. R., Stasny, J. T., Rubin, B. A., Fontes, A. K., Pierzchala, W. A., Wiener, F. P. & Hartzell, R. W. (1970). The effect of non-aqueous solvents on the quaternary structure of viruses: Properties of haemagglutinins obtained by disruption of influenza viruses with tri(n-butyl)phosphate. Microbios 2, 209–24.Google Scholar
Peck, F. B. (1968). Purified influenza virus vaccine, a study of viral reactivity and anti-genicity. Journal of the American Medical Association 206 (10), 2277–82.CrossRefGoogle Scholar
Potter, C. W., Jennings, R., McLaren, C., Edey, Dorothy, Stuart-Harris, C. H. & Brady, Margaret (1975). A new surface-antigen-adsorbed influenza virus vaccine. II. Studies in a volunteer group. Journal of Hygiene 75, 353–62.CrossRefGoogle Scholar
Quilligan, J. J. Jr., Salgado, P. F. & Alena, B. (1961). Influenza vaccination in children. American Journal of Diseases in Children 101, 593601.Google Scholar
Reimer, C. B., Baker, R. S., van Frank, R. M., Newlin, T. E., Cline, G. B. & Anderson, N. G. (1967). Purification of large quantities of influenza virus by density gradient centrifugation. Journal of Virology 1 (6), 1207–16.Google ScholarPubMed
Ruben, F. L. & Jackson, G. G. (1972). A new subunit influenza vaccine; acceptability compared with standard vaccines and effect of dose on antigenicity. Journal of Infectious Diseases 125 (6), 656–64.CrossRefGoogle ScholarPubMed
Schild, G. C., Henry-Aymard, M. & Pereira, H. G. (1972). A quantitative single-radial-diffusion test for immunological studies with influenza virus. Journal of General Virology 16, 231–6.CrossRefGoogle ScholarPubMed
Siegert, R. & Braune, P. (1964). The pyrogens of myxoviruses. II. Resistance of influenza A pyrogens to heat, ultraviolet and chemical treatment. Virology 24, 218–24.CrossRefGoogle ScholarPubMed
Slepushkin, A. N., Schild, G. C., Beare, A. S., Chinn, Susan & Tyrrell, D. A. J. (1971). Neuraminidase and resistance to vaccination with live influenza A Hong Kong vaccines. Journal of Hygiene 69, 571–8.CrossRefGoogle ScholarPubMed
Warburton, M. F. & Duxbury, A. E. (1973). Deoxycholate split influenza virus vaccines in infants and young children. International symposium on influenza vaccines for men and horses. Symposium Series & Immunobiological Standardisation 20, 9298.Google Scholar
Warren, L. (1959). The thiobarbituric acid assay of sialic acids. Journal of Biological Chemistry 234 (8), 1971–75.Google Scholar
Webster, R. G. & Laver, W. G. (1966). Influenza virus subunit vaccines, immunogenicity and lack of toxicity for rabbits of ether- and detergent-disrupted virus. Journal of Immunology 96 (4), 596605.Google ScholarPubMed
World Health Organization (1953). First report of the expert committee on influenza.Google Scholar